Slow wave sleep in humans: Role of 5-HT2A and 5-HT2C receptors
- 30 April 1994
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 33 (3-4) , 467-471
- https://doi.org/10.1016/0028-3908(94)90077-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- meta-Chlorophenylpiperazine decreases slow-wave sleep in humansBiological Psychiatry, 1993
- A dose‐response study examining the effects of ritanserin on human slow wave sleep.British Journal of Clinical Pharmacology, 1991
- KetanserinDrugs, 1990
- Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humansPsychopharmacology, 1990
- Increased slow wave sleep with 5-HT2 receptor antagonists: detection by ambulatory EEG recording and automatic sleep stage analysisJournal of Psychopharmacology, 1989
- 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brainBiological Psychiatry, 1989
- Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonismLife Sciences, 1989
- 5-HT2 receptors could be primarily involved in the regulation of slow-wabe sleep in the ratEuropean Journal of Pharmacology, 1987
- Safety Evaluation of Ritanserin—An Investigational Serotonin AntagonistDrug Intelligence & Clinical Pharmacy, 1986
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973